During recent years, with GnRH antagonist protocol (GnRHa) becoming more widely used, gonadotropin releasing hormone agonist (GnRHa), as a trigger has gained popularity, alternative to hCG in the prevention of OHSS in PCOS patients undergoing IVF cycles (4). This evidence concerns the gene GNRH1 and polycystic ovary syndrome.